OssDsign: Summary of the Strategy Update Event and comments on the rights issue

Research Note



Redeye returns with a summary of OssDsign’s Strategy Update held at Redeye on March 2nd, as well as a brief comment on the equity issue aiming to raise SEK 240-270m. We are pleased to see that the company accelerates its efforts to reach its full potential, both with its cranial implant and the new vertical in orthobiologics.


Oscar Bergman

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.